Teva Pharmaceuticals

The pair's Indian rival Dr.Reddy's Laboratories is currently locked in a legal battle in the United States to re-launch a cheaper version of the UK drugmaker's Suboxone Film.

Teva offers to buy out Mylan: What does it mean for Natco

Natco is engaged in a legal battle to launch a generic version of Teva's top-selling drug Copaxone, patent on which expires in September.

Cipla up 3% on collaboration with Teva for South Africa

The collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively market Teva's broad pharmaceutical product portfolio in South Africa, says the company in its filing.

Patent win against Teva to boost revenues: Natco Pharma

Bhaskar Narayana, Finance Director & CFO, Natco Pharma is confident of maintaining the current growth rate in terms of margins going forward.

Natco Pharma surges further on patent case win against Teva

The main booster for the stock is its victory in a patent battle against Israeli drug-giant Teva Pharmaceuticals over USD 4 billion multiple Sclerosis drug Copaxone.

Sun Pharma surges after April-June results

Sun, India's top drugmaker by market value, reported on Friday a net loss of Rs 1276 crore for the June quarter, due to a provisioning charge to settle a patent suit

Dilip Shangvi's Sun Pharma enters next phase of growth

Dilip Shanghvi built Sun Pharma into one of the most profitable generic drugs companies in the world. Now, he's stepped back and brought in Israel Makov to steer Sun into its next growth phase.

Ranbaxy face value at Rs 510-520; exit on rally: Edelweiss

In an interview to CNBC-TV18, Manoj Garg, VP, institutional equities – research of Edelweiss Securities says, one should exit Ranbaxy on rally. “The face value of the stock would be in the vicinity of around Rs 510-520.”

Ranbaxy jumps after final nod from USFDA to launch Lipitor

Ranbaxy’s shares jumped over 10% in morning trade on Thursday after it said it has launched its generic version of Lipitor in the US market having received final approval from US Food and Drugs Administration (FDA).